Lincoln National Corp’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,255
Closed -$60.4K 1009
2022
Q4
$60.4K Sell
17,255
-21,775
-56% -$76.2K ﹤0.01% 906
2022
Q3
$308K Hold
39,030
0.01% 644
2022
Q2
$307K Sell
39,030
-220
-0.6% -$1.73K 0.01% 643
2022
Q1
$477K Hold
39,250
0.01% 542
2021
Q4
$480K Buy
39,250
+12,950
+49% +$158K 0.01% 536
2021
Q3
$274K Buy
+26,300
New +$274K 0.01% 718